GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » 3-Year EPS without NRI Growth Rate

Odyssey Group International (Odyssey Group International) 3-Year EPS without NRI Growth Rate : -10.80% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International 3-Year EPS without NRI Growth Rate?

Odyssey Group International's EPS without NRI for the three months ended in Jan. 2024 was $0.04.

During the past 3 years, the average EPS without NRI Growth Rate was -10.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -41.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of Odyssey Group International was 35.80% per year. The lowest was -598.00% per year. And the median was -118.30% per year.


Competitive Comparison of Odyssey Group International's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Odyssey Group International's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Group International's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's 3-Year EPS without NRI Growth Rate falls into.



Odyssey Group International 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Odyssey Group International  (OTCPK:ODYY) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Odyssey Group International 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Group International (Odyssey Group International) Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087